BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9072430)

  • 1. Cardiovascular and renal protective effects of losartan in spontaneously hypertensive rats with diabetes mellitus.
    Kohzuki M; Yasujima M; Liu PF; Obara K; Kanazawa M; Yoshida K; Saito T; Sato T; Abe K
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S366-7. PubMed ID: 9072430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
    Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K
    J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
    Rodrigo E; Maeso R; Muñoz-García R; Navarro-Cid J; Ruilope LM; Cachofeiro V; Lahera V
    J Hypertens; 1997 Jun; 15(6):613-8. PubMed ID: 9218180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoregulation of total and zonal glomerular filtration rate in spontaneously hypertensive rats during antihypertensive therapy.
    Wang X; Aukland K; Iversen BM
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):833-41. PubMed ID: 8961082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin angiotensin system and nociception in spontaneously hypertensive rats.
    Irvine RJ; White JM; Head RJ
    Life Sci; 1995 Feb; 56(13):1073-8. PubMed ID: 9001440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats.
    Cao Z; Bonnet F; Davis B; Allen TJ; Cooper ME
    Clin Sci (Lond); 2001 Jun; 100(6):591-9. PubMed ID: 11352773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after myocardial infarction in rats: captopril versus losartan.
    Milavetz JJ; Raya TE; Johnson CS; Morkin E; Goldman S
    J Am Coll Cardiol; 1996 Mar; 27(3):714-9. PubMed ID: 8606287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
    Stier CT; Adler LA; Levine S; Chander PN
    J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional tolerance to alpha-adrenergic receptor blockade in the spontaneously hypertensive rat highlights the multifunctional role of vascular angiotensin II in the development of hypertension.
    Smid SD; Frewin DB; Wyartt CL; Head RJ
    J Vasc Res; 1995; 32(4):247-53. PubMed ID: 7654881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
    Nagura J; Yamamoto M; Hui C; Yasuda S; Hachisu M; Konno F
    Clin Exp Pharmacol Physiol; 1996 Mar; 23(3):229-35. PubMed ID: 8934613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor blockers. A new class of antihypertensive drugs.
    Velasquez MT
    Arch Fam Med; 1996 Jun; 5(6):351-6. PubMed ID: 8640326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan protects the rat kidney from ischemic injury.
    Heller J; Kramer HJ; Cervenka L; Hellerová S
    Kidney Int Suppl; 1996 Jun; 55():S113-4. PubMed ID: 8743528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide angiotensin II type 1 receptor antagonist prevents nephrosclerosis in hypertensive rats.
    Kanno Y; Okada H; Suzuki H; Ikenaga H; Saruta T
    Blood Press Suppl; 1994; 5():67-70. PubMed ID: 7889204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal.
    Fornes P; Richer C; Vacher E; Bruneval P; Giudicelli JF
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):305-13. PubMed ID: 7692174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y
    Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain "ouabain" and angiotensin II in salt-sensitive hypertension in spontaneously hypertensive rats.
    Huang BS; Leenen FH
    Hypertension; 1996 Dec; 28(6):1005-12. PubMed ID: 8952589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor antagonists.
    Goldsmith DJ
    Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
    Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
    J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O; Kushida H; Kunihara M
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.